<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">SJP</journal-id>
<journal-id journal-id-type="hwp">spsjp</journal-id>
<journal-id journal-id-type="nlm-ta">Scand J Public Health</journal-id>
<journal-title>Scandinavian Journal of Public Health</journal-title>
<issn pub-type="ppub">1403-4948</issn>
<issn pub-type="epub">1651-1905</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1403494813479216</article-id>
<article-id pub-id-type="publisher-id">10.1177_1403494813479216</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Short Communications</subject></subj-group></article-categories>
<title-group>
<article-title>Cutaneous malignant melanoma incidence rates in Norway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Moan</surname><given-names>Johan</given-names></name>
<xref ref-type="aff" rid="aff1-1403494813479216">1</xref>
<xref ref-type="aff" rid="aff2-1403494813479216">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Baturaite</surname><given-names>Zivile</given-names></name>
<xref ref-type="aff" rid="aff1-1403494813479216">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Grigalavicius</surname><given-names>Mantas</given-names></name>
<xref ref-type="aff" rid="aff1-1403494813479216">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Juzeniene</surname><given-names>Asta</given-names></name>
<xref ref-type="aff" rid="aff1-1403494813479216">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1403494813479216">
<label>1</label>Department of Radiation Biology, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Montebello, Norway</aff>
<aff id="aff2-1403494813479216">
<label>2</label>Department of Physics, University of Oslo, Oslo, Norway</aff>
<author-notes>
<corresp id="corresp1-1403494813479216">Zivile Baturaite, Department of Radiation Biology, The Norwegian Radium Hospital, Ullernchausseen 70, N-0310 Oslo, Norway. E-mail: <email>zivile.baturaite@rr-research.no</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>4</issue>
<fpage>336</fpage>
<lpage>339</lpage>
<history>
<date date-type="accepted">
<day>27</day>
<month>1</month>
<year>2013</year></date></history>
<permissions>
<copyright-statement>© 2013 the Nordic Societies of Public Health</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Associations of Public Health in the Nordic Countries Regions</copyright-holder>
</permissions>
<abstract>
<p><italic>Aims</italic>: The incidence rates of cutaneous malignant melanoma (CMM) increase throughout the world, in spite of introduction of strategies for prevention. However, a decrease in incidence rates is observed in some countries. If the reason for this could be found, it might be useful to transfer the knowledge to other fields of medicine. <italic>Methods</italic>: CMM age-standardized incidence rates in different age groups in Norway were obtained from NORDCAN for the years 1970–1989 and 1990–2009. <italic>Results</italic>: Until 1990, the CMM rates increased, but after that time a stabilization or a decrease was observed for young age groups (15–54 years old), while in older generations (&gt;55 years old) the rates continued to increase. <bold><italic>Conclusions</italic>: The decreasing CMM pattern in young age groups may be due to changing patterns to sunlight in sunbathing and use of sunbeds.</bold></p>
</abstract>
<kwd-group>
<kwd>Cutaneous malignant melanoma</kwd>
<kwd>epidemiology</kwd>
<kwd>Norway</kwd>
<kwd>ultraviolet radiation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1403494813479216" sec-type="intro">
<title>Introduction</title>
<p>Increasing incidence trends of cutaneous malignant melanoma (CMM) in fair-skinned populations have been observed in many countries [<xref ref-type="bibr" rid="bibr1-1403494813479216">1</xref><xref ref-type="bibr" rid="bibr2-1403494813479216"/><xref ref-type="bibr" rid="bibr3-1403494813479216"/><xref ref-type="bibr" rid="bibr4-1403494813479216"/>–<xref ref-type="bibr" rid="bibr5-1403494813479216">5</xref>]. It is debated if this increase represents a real melanoma increase or this might have been caused by overdiagnosis or diagnostic drift [<xref ref-type="bibr" rid="bibr6-1403494813479216">6</xref><xref ref-type="bibr" rid="bibr7-1403494813479216"/>–<xref ref-type="bibr" rid="bibr8-1403494813479216">8</xref>]. It has been claimed that the diagnosis of CMM has become more inclusive [<xref ref-type="bibr" rid="bibr7-1403494813479216">7</xref><xref ref-type="bibr" rid="bibr8-1403494813479216"/><xref ref-type="bibr" rid="bibr9-1403494813479216"/><xref ref-type="bibr" rid="bibr10-1403494813479216"/>–<xref ref-type="bibr" rid="bibr11-1403494813479216">11</xref>]. An increasing fraction of CMM diagnoses, previously diagnosed as simple or dysplastic nevi, may now being diagnosed as CMM [<xref ref-type="bibr" rid="bibr7-1403494813479216">7</xref>,<xref ref-type="bibr" rid="bibr9-1403494813479216">9</xref>]. CMM increase may be also due to changing habits of sunbathing and sunbeds [<xref ref-type="bibr" rid="bibr12-1403494813479216">12</xref><xref ref-type="bibr" rid="bibr13-1403494813479216"/>–<xref ref-type="bibr" rid="bibr14-1403494813479216">14</xref>].</p>
<p>In 2009, 1405 new cases of CMM and 295 deaths from CMM were reported in Norway [<xref ref-type="bibr" rid="bibr15-1403494813479216">15</xref>]. In young age groups (&lt;50 years old), CMM is among the three most-frequent cancers [<xref ref-type="bibr" rid="bibr15-1403494813479216">15</xref>]. Our objective was to present CMM time trends for different age groups in Norway. The same diagnostic procedures are used in the whole country, and possible changes of these procedures should influence the epidemiology similarly for all age groups. However, sun exposure patterns, and changes in these patterns, are certainly different for different age groups.</p>
</sec>
<sec id="section2-1403494813479216" sec-type="materials|methods">
<title>Materials and methods</title>
<p>CMM age-standardized (world population) incidence rates (per 100,000 person-years) by different age groups for males and females in Norway (1970–2009) were obtained from the online database NORDCAN [<xref ref-type="bibr" rid="bibr15-1403494813479216">15</xref>]. Age groups were selected as follows: 15–24, 25–34, 35–44, 45–54, 55–64, 65–74 years old, and older than 75 years. Data are represented in logarithmic scale (<xref ref-type="fig" rid="fig1-1403494813479216">Figure 1</xref>).</p>
<fig id="fig1-1403494813479216" position="float">
<label>Figure 1.</label>
<caption>
<p>Age-standardized (world population) incidence rates per 100,000 persons for different age groups for males (A) and females (B) in Norway (1970–2009).</p>
</caption>
<graphic xlink:href="10.1177_1403494813479216-fig1.tif"/></fig>
<p>For statistical reasons, only two periods, 1970–1989 and 1990–2009, were chosen to evaluate time trends. Slopes of polynomial regression functions were determined for different age groups (<xref ref-type="fig" rid="fig2-1403494813479216">Figure 2</xref>). The data were analysed using SigmaPlot 11.0 software from Systat Software, Inc. (Richmond, CA, USA). Significant <italic>p</italic>-value was considered below 0.05.</p>
<fig id="fig2-1403494813479216" position="float">
<label>Figure 2.</label>
<caption>
<p>Slopes of CMM incidence rates, as given in <xref ref-type="fig" rid="fig1-1403494813479216">Figure 1</xref>, for different age groups and gender, males (A) and females (B), in Norway in two periods: 1970–1989 and 1990–2009. Significant <italic>p</italic>-values are marked with ٭.</p>
</caption>
<graphic xlink:href="10.1177_1403494813479216-fig2.tif"/></fig>
</sec>
<sec id="section3-1403494813479216" sec-type="results">
<title>Results</title>
<p>The time trends of CMM incidence rates are different for different age groups in Norway (<xref ref-type="fig" rid="fig1-1403494813479216">Figure 1</xref>). Slopes were calculated to get more information about differences in time trends for the two periods (1970–1989 and 1990–2009) separately (<xref ref-type="fig" rid="fig2-1403494813479216">Figure 2</xref>). All slopes in the first period (1970–1989) are positive, showing significantly increasing (<italic>p</italic> &lt;0.05) trends for both sexes and all age groups, except the youngest (15–24 years old) male group. However, for the second period (1990–2009), all slopes are negative or close to zero for age groups up to 45–54 years, indicating decreasing or constant CMM incidence rates (<xref ref-type="fig" rid="fig2-1403494813479216">Figure 2</xref>). A statistically significant decrease of CMM was found for males in the 25–34 and 45–54 age groups and for females in the 15–24 year-group. For men and women older than 55 years, the incidence rates are increasing (<italic>p</italic> &lt;0.05) in the whole period (1970–2009).</p>
<p>In the first period, the slopes are increasing with age up to 55–75 years and then reach a constant level. For the oldest age group, the slopes are larger in the late (1990–2009) than in the early (1970–1989) period.</p>
</sec>
<sec id="section4-1403494813479216" sec-type="results">
<title>Discussion</title>
<p>The present work indicates that the time trends of CMM in Norway are different for young (15–54 years old) and for old (&gt;54 years old) persons: after about 1990, the rates among young persons (≤ 54 years old) are stable or decrease. Such trends have been observed earlier, not only in Norway, but also in Australia, New Zealand, Canada and Sweden of predominantly fair-skinned populations [<xref ref-type="bibr" rid="bibr10-1403494813479216">10</xref>,<xref ref-type="bibr" rid="bibr16-1403494813479216">16</xref><xref ref-type="bibr" rid="bibr17-1403494813479216"/><xref ref-type="bibr" rid="bibr18-1403494813479216"/><xref ref-type="bibr" rid="bibr19-1403494813479216"/><xref ref-type="bibr" rid="bibr20-1403494813479216"/>–<xref ref-type="bibr" rid="bibr21-1403494813479216">21</xref>].</p>
<p>Several studies indicate interaction between environmental, genetic and individual behavior-related factors in melanomagenesis [<xref ref-type="bibr" rid="bibr22-1403494813479216">22</xref>,<xref ref-type="bibr" rid="bibr23-1403494813479216">23</xref>]. Sunbeds play a role for CMM risk [<xref ref-type="bibr" rid="bibr12-1403494813479216">12</xref>,<xref ref-type="bibr" rid="bibr24-1403494813479216">24</xref><xref ref-type="bibr" rid="bibr25-1403494813479216"/>–<xref ref-type="bibr" rid="bibr26-1403494813479216">26</xref>]. Sunbed use has increased since 1980 for all age groups in Norway, from 1% of the population in 1980 to about 30% in 2011 [<xref ref-type="bibr" rid="bibr27-1403494813479216">27</xref>], while a significant decrease or stabilization in CMM rates among persons younger than 54 years of age are observed (<xref ref-type="fig" rid="fig1-1403494813479216">Figures 1</xref>–<xref ref-type="fig" rid="fig2-1403494813479216">2</xref>). This decrease can be explained by several campaigns against excessive exposure to sun and use of sunbeds. Public health campaigns encourage people to protect themselves against skin cancer by using sunscreens and avoiding sun. However, one would think that such campaigns should have a larger impact on the behaviour on adults than on young persons. This is not supported by the present data which show a much larger change in the CMM trends around 1990 for young than for older persons (<xref ref-type="fig" rid="fig1-1403494813479216">Figures 1</xref>–<xref ref-type="fig" rid="fig2-1403494813479216">2</xref>). Two other factors should be considered in the future: increasing living standards and leisure time may lead to more vacational and outdoor activities, notably among middle-aged and older persons. Among young persons, there is an increasing popularity of indoor activities. Both of these factors may definitely lead to less outdoor activities for young persons and may explain our data. Support of this view comes from the observation that the vitamin D-levels among teenagers in Norway are low [<xref ref-type="bibr" rid="bibr28-1403494813479216">28</xref>]. A major source of vitamin D is exposure to sunlight, even at the high latitudes [<xref ref-type="bibr" rid="bibr29-1403494813479216">29</xref>]. Unfortunately, no data concerning the time trends of the vitamin D status are available so far.</p>
<p>The changes of the slopes from about 55 years are largest for the 1990–2009 period. For the 1970–1989 period, the slopes are large but remain almost unchanged with age after 55 years. This is again supporting the assumption that the improvement of living standard plays a role. It is likely that the effect of the living standard increase with age, just in agreement with <xref ref-type="fig" rid="fig2-1403494813479216">Figure 2</xref>. Elderly persons have increased their time spent outdoors more in the latest two decades than they did earlier. Vacations to southern latitudes are linked to living standard and may be involved in this.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The present work was supported by the South-Eastern Norway Regional Health Authority and by Oslo University Hospital.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1403494813479216">
<label>[1]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giblin</surname><given-names>AV</given-names></name>
<name><surname>Thomas</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Incidence, mortality and survival in cutaneous melanoma</article-title>. <source>J Plast Reconstr Aesthet Surg</source> <year>2007</year>;<volume>60</volume>:<fpage>32</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr2-1403494813479216">
<label>[2]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Godar</surname><given-names>DE</given-names></name>
</person-group>. <article-title>Worldwide increasing incidences of cutaneous malignant melanoma</article-title>. <source>J Skin Cancer</source> <year>2011</year>;<volume>165</volume>(<issue>2</issue>):<fpage>349</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr3-1403494813479216">
<label>[3]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Erdmann</surname><given-names>F</given-names></name>
<name><surname>Lortet-Tieulent</surname><given-names>J</given-names></name>
<name><surname>Schuz</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>International trends in the incidence of malignant melanoma 1953–2008 - are recent generations at higher or lower risk?</article-title> <source>Int J Cancer</source>. Epub ahead of print <day>24</day> <month>April</month> <year>2012</year>. DOI: <pub-id pub-id-type="doi">10.1002/ijc.27616</pub-id>.</citation>
</ref>
<ref id="bibr4-1403494813479216">
<label>[4]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garbe</surname><given-names>C</given-names></name>
<name><surname>Leiter</surname><given-names>U</given-names></name>
</person-group>. <article-title>Melanoma epidemiology and trends</article-title>. <source>Clin Dermatol</source> <year>2009</year>;<volume>27</volume>:<fpage>3</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr5-1403494813479216">
<label>[5]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jemal</surname><given-names>A</given-names></name>
<name><surname>Saraiya</surname><given-names>M</given-names></name>
<name><surname>Patel</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006</article-title>. <source>J Am Acad Dermatol</source> <year>2011</year>;<volume>65</volume>:<fpage>S17</fpage>–<lpage>S25</lpage>.</citation>
</ref>
<ref id="bibr6-1403494813479216">
<label>[6]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hollestein</surname><given-names>LM</given-names></name>
<name><surname>van den Akker</surname><given-names>SA</given-names></name>
<name><surname>Nijsten</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989</article-title>. <source>Ann Oncol</source> <volume>2012</volume>;<issue>23</issue>: <fpage>524</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr7-1403494813479216">
<label>[7]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levell</surname><given-names>NJ</given-names></name>
<name><surname>Beattie</surname><given-names>CC</given-names></name>
<name><surname>Shuster</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Melanoma epidemic: a midsummer night’s dream?</article-title> <source>Br J Dermatol</source> <year>2009</year>; <volume>161</volume>:<fpage>630</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr8-1403494813479216">
<label>[8]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Downing</surname><given-names>A</given-names></name>
<name><surname>Newton-Bishop</surname><given-names>JA</given-names></name>
<name><surname>Forman</surname><given-names>D</given-names></name>
</person-group>. <article-title>Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993–2003</article-title>. <source>Br J Cancer</source> <year>2006</year>;<volume>95</volume>:<fpage>91</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr9-1403494813479216">
<label>[9]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frangos</surname><given-names>JE</given-names></name>
<name><surname>Duncan</surname><given-names>LM</given-names></name>
<name><surname>Piris</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Increased diagnosis of thin superficial spreading melanomas: a 20-year study</article-title>. <source>J Am Acad Dermatol</source> <year>2011</year>;<volume>67</volume>(<issue>3</issue>):<fpage>387</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr10-1403494813479216">
<label>[10]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coory</surname><given-names>M</given-names></name>
<name><surname>Baade</surname><given-names>P</given-names></name>
<name><surname>Aitken</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002</article-title>. <source>Cancer Causes Control</source> <year>2006</year>; <volume>17</volume>: <fpage>21</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr11-1403494813479216">
<label>[11]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lipsker</surname><given-names>DM</given-names></name>
<name><surname>Hedelin</surname><given-names>G</given-names></name>
<name><surname>Heid</surname><given-names>E</given-names></name>
<etal/></person-group>. <article-title>Striking increase of thin melanomas contrasts with stable incidence of thick melanomas</article-title>. <source>Arch Dermatol</source> <year>1999</year>;<volume>135</volume>:<fpage>1451</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr12-1403494813479216">
<label>[12]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boniol</surname><given-names>M</given-names></name>
<name><surname>Autier</surname><given-names>P</given-names></name>
<name><surname>Boyle</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis</article-title>. <source>BMJ</source>. Epub ahead of print <day>24</day> <month>July</month> <year>2012</year>. DOI: <pub-id pub-id-type="doi">10.1136/bmj.e4757</pub-id>.</citation>
</ref>
<ref id="bibr13-1403494813479216">
<label>[13]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Vries</surname><given-names>E</given-names></name>
<name><surname>Coebergh</surname><given-names>JW</given-names></name>
</person-group>. <article-title>Cutaneous malignant melanoma in Europe</article-title>. <source>Eur J Cancer</source> <year>2004</year>;<volume>40</volume>:<fpage>2355</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr14-1403494813479216">
<label>[14]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Veierod</surname><given-names>MB</given-names></name>
<name><surname>Adami</surname><given-names>HO</given-names></name>
<name><surname>Lund</surname><given-names>E</given-names></name>
<etal/></person-group>. <article-title>Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <year>2010</year>;<volume>19</volume>:<fpage>111</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr15-1403494813479216">
<label>[15]</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Engholm</surname><given-names>G</given-names></name>
<name><surname>Ferlay</surname><given-names>J</given-names></name>
<name><surname>Christensen</surname><given-names>N</given-names></name>
<etal/></person-group>. <article-title>NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 5.1 (March 2012). Association of the Nordic Cancer Registries</article-title>. <source>Danish Cancer Society</source>, <ext-link ext-link-type="uri" xlink:href="http://www-dep.iarc.fr/NORDCAN/english/frame.asp">http://www-dep.iarc.fr/NORDCAN/english/frame.asp</ext-link> (<year>2012</year>, <access-date>accessed 1 August 2012</access-date>).</citation>
</ref>
<ref id="bibr16-1403494813479216">
<label>[16]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Vries</surname><given-names>E</given-names></name>
<name><surname>Bray</surname><given-names>FI</given-names></name>
<name><surname>Coebergh</surname><given-names>JW</given-names></name>
<etal/></person-group>. <article-title>Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia</article-title>. <source>Int J Cancer</source> <year>2003</year>;<volume>107</volume>:<fpage>119</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr17-1403494813479216">
<label>[17]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pruthi</surname><given-names>DK</given-names></name>
<name><surname>Guilfoyle</surname><given-names>R</given-names></name>
<name><surname>Nugent</surname><given-names>Z</given-names></name>
<etal/></person-group>. <article-title>Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005</article-title>. <source>J Am Acad Dermatol</source> <year>2009</year>;<volume>61</volume>:<fpage>44</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr18-1403494813479216">
<label>[18]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Whiteman</surname><given-names>DC</given-names></name>
<name><surname>Bray</surname><given-names>CA</given-names></name>
<name><surname>Siskind</surname><given-names>V</given-names></name>
<etal/></person-group>. <article-title>Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?</article-title> <source>Eur J Cancer Prev</source> <year>2008</year>;<volume>17</volume>:<fpage>243</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr19-1403494813479216">
<label>[19]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richardson</surname><given-names>A</given-names></name>
<name><surname>Fletcher</surname><given-names>L</given-names></name>
<name><surname>Sneyd</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994–2004</article-title>. <source>N Z Med J</source> <year>2008</year>;<volume>121</volume>:<fpage>18</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr20-1403494813479216">
<label>[20]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karlsson</surname><given-names>PM</given-names></name>
<name><surname>Fredrikson</surname><given-names>M</given-names></name>
</person-group>. <article-title>Cutaneous malignant melanoma in children and adolescents in Sweden, 1993–2002: the increasing trend is broken</article-title>. <source>Int J Cancer</source> <year>2007</year>;<volume>121</volume>:<fpage>323</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr21-1403494813479216">
<label>[21]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Youl</surname><given-names>PH</given-names></name>
<name><surname>Youlden</surname><given-names>DR</given-names></name>
<name><surname>Baade</surname><given-names>PD</given-names></name>
</person-group>. <article-title>Changes in the site distribution of common melanoma sub-types in Queensland, Australia over time: implications for public health campaigns</article-title>. <source>Br J Dermatol</source>. Epub ahead of print <day>21</day> <month>May</month> <year>2012</year>. DOI: <pub-id pub-id-type="doi">10.1111/j.1365–2133.2012.11064.x</pub-id>.</citation>
</ref>
<ref id="bibr22-1403494813479216">
<label>[22]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Russak</surname><given-names>JE</given-names></name>
<name><surname>Rigel</surname><given-names>DS</given-names></name>
</person-group>. <article-title>Risk factors for the development of primary cutaneous melanoma</article-title>. <source>Dermatol Clin</source> <year>2012</year>;<volume>30</volume>:<fpage>363</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr23-1403494813479216">
<label>[23]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Whiteman</surname><given-names>DC</given-names></name>
<name><surname>Whiteman</surname><given-names>CA</given-names></name>
<name><surname>Green</surname><given-names>AC</given-names></name>
</person-group>. <article-title>Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies</article-title>. <source>Cancer Causes Control</source> <year>2001</year>;<volume>12</volume>:<fpage>69</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr24-1403494813479216">
<label>[24]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cust</surname><given-names>AE</given-names></name>
<name><surname>Armstrong</surname><given-names>BK</given-names></name>
<name><surname>Goumas</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma</article-title>. <source>Int J Cancer</source> <year>2011</year>;<volume>128</volume>:<fpage>2425</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr25-1403494813479216">
<label>[25]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Autier</surname><given-names>P</given-names></name>
<name><surname>Dore</surname><given-names>JF</given-names></name>
<name><surname>Eggermont</surname><given-names>AM</given-names></name>
<etal/></person-group>. <article-title>Epidemiological evidence that UVA radiation is involved in the genesis of cutaneous melanoma</article-title>. <source>Curr Opin Oncol</source> <year>2011</year>;<volume>23</volume>:<fpage>189</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr26-1403494813479216">
<label>[26]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coelho</surname><given-names>SG</given-names></name>
<name><surname>Hearing</surname><given-names>VJ</given-names></name>
</person-group>. <article-title>UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women</article-title>. <source>Pigment Cell Melanoma Res</source> <year>2010</year>;<volume>23</volume>: <fpage>57</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr27-1403494813479216">
<label>[27]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moan</surname><given-names>J</given-names></name>
<name><surname>Baturaite</surname><given-names>Z</given-names></name>
<name><surname>Grigalavicius</surname></name>
<etal/>
</person-group>. <article-title>The UV dilemma: melanomagenesis versus vitamin D photosynthesis (manuscript in preparation)</article-title>.</citation>
</ref>
<ref id="bibr28-1403494813479216">
<label>[28]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lagunova</surname><given-names>Z</given-names></name>
<name><surname>Porojnicu</surname><given-names>AC</given-names></name>
<name><surname>Lindberg</surname><given-names>FA</given-names></name>
<etal/></person-group>. <article-title>Vitamin D status in Norwegian children and adolescents with excess body weight</article-title>. <source>Pediatr Diabetes</source> <year>2011</year>;<volume>12</volume>:<fpage>120</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr29-1403494813479216">
<label>[29]</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holick</surname><given-names>MF</given-names></name>
<name><surname>Binkley</surname><given-names>NC</given-names></name>
<name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name>
<etal/></person-group>. <article-title>Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline</article-title>. <source>J Clin Endocrinol Metab</source> <year>2011</year>;<volume>96</volume>:<fpage>1911</fpage>–<lpage>30</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>